Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study

Movement Disorders

Volumn 24, Issue 9, 2009, Pages 1312-1318

  Kanazawa, Masato ^a   Shimohata, Takayoshi ^a   Toyoshima, Yasuko ^a   Tada, Mari ^a   Kakita, Akiyoshi ^a   Morita, Takashi ^b   Ozawa, Tetsutaro ^a   Takahashi, Hitoshi ^a   Nishizawa, Masatoyo ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Shinrakuen Hospital   (Japan)

Author keywords

Parkinson's disease; Parkinsonian disorders; Progressive supranuclear palsy; Spinocerebell arataxias

Indexed keywords

TAU PROTEIN;

AGED; ARTICLE; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CLINICAL FEATURE; COILED BODY; CONTROLLED STUDY; DENTATE NUCLEUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC HETEROGENEITY; GLIOSIS; HUMAN; JAPANESE; MALE; NERVE CELL DEGENERATION; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PURKINJE CELL;

AGED; AGED, 80 AND OVER; CELL DEATH; CEREBELLUM; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NERVE TISSUE PROTEINS; NEURONS; RETROSPECTIVE STUDIES; SILVER STAINING; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 69549088659     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22583     Document Type: Article

References (26)

1. Richardson JC, Steele JC, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. Trans Am Neurol Assoc 1963;88:25-29.
2. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57:1497-1499.
3. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism. Brain 2005;128:1247-1258.
4. Williams DR, Holton JL, Strand K, et al. Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22:2235-2241.
5. Collins SJ, Ahlskog JE, Parisi JE, et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
6. Kaat LD, Boon AJ, Kamphorst W, et al. Frontal presentation in progressive supranuclear palsy. Neurology 2007;69:723-729.
7. Ahmed Z, Josephs KA, Gonzalez J, et al. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 2008;131:460-472.
8. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
9. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(Suppl. 2):II6-II15.
10. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007;17:74-82.
11. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
12. Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry 2006;77:468-473.
13. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
14. Piao YS, Hayashi S, Wakabayashi K, et al. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol (Berl) 2002;103:469-474.
15. Wenning GK, Seppi K, Tison F, et al. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002;109:307-320.
16. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127:2657-2671.
17. Birdi S, Rajput AH, Fenton M, et al. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 2002;17:1255-1264.
18. Uchikado H, DelleDonne A, Ahmed Z, et al. Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 2006;65:387-395.
19. Tsuboi Y, Josephs KA, Boeve BF, et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 2005;20:982-988.
20. Soliveri P, Piacentini S, Girotti F. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2005;64:448-453.
21. Josephs KA, Duffy JR, Strand EA, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006;129:1385-1398.
22. Josephs KA, Katsuse O, Beccano-Kelly DA, et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 2006;65:396-405.
23. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy - a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-359.
24. Utsumi H, Abe K, Yoshii O, et al. A 71-year-old woman with progressive gait disturbance and dementia. No To Shinkei 1995; 47:295-307.
25. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-Parkinsonism from Richardson's syndrome. Brain 2007;130:1566-1576.
26. Hardy J, Pittman A, Myers A, et al. Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens. Biochem Soc Trans 2005;33:582-585.